Skip to content

Platelet Function and Neurological Events

Platelet Function and Neurological Events Following Carotid Thromboendarterectomy

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05572320
Acronym
MULTINEUR
Enrollment
650
Registered
2022-10-07
Start date
2022-10-10
Completion date
2025-09-20
Last updated
2026-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carotid Artery Diseases, Stroke, Acute

Keywords

Carotid thromboendarterectomy, Thromboembolic Stroke, Platelet function, Aggregometry, Vascular surgery, mortality, neurological events

Brief summary

Several studies have shown an association between platelet function and stroke in patients undergoing carotid thromboendarterectomy (TEA). The present study will assess the correlation between platelet function evaluated by the impedance aggregometry and neurological events in patients undergoing carotid TEA.

Detailed description

Carotid thrombendarterectomy (TEA) is effective in preventing strokes which are a major cause of mortality and morbidity. Nevertheless, almost 10% of patients undergoing TEA develop a transient and/or permanent neurological injury. There is a growing body of evidence that platelet function is associated with perioperative neurological events in this setting, although the vast majority of patients undergoing carotid TEA are already on antiplatelet agents. The aim of the present study will be to assess the correlation between the platelet function evaluated by the impedance aggregometry (Multiplate ® Analyzer, Roche, Basel, Switzerland) and neurological events in patients undergoing carotid TEA.

Interventions

DIAGNOSTIC_TESTPlatelet Aggregometry Testing

1.6 ml of blood collected in hirudin-coated tubes before the surgery

Sponsors

Scientific Institute San Raffaele
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \> 18 years * Carotid Artery Diseases undergoing carotid thrombendarterectomy * Signed consent

Exclusion criteria

* Atrial fibrillation * New oral anticoagulant * Oral Vitamin k inhibitors * Platelet count \<80000 per microliter * Ongoing ischemic stroke

Design outcomes

Primary

MeasureTime frameDescription
Platelet function and neurological eventsimmediately before the surgeryThe platelet function will be evaluated by Multiple Electrode Aggregometry (Multiplate). It will be asses the correlation between thrombin receptor activator peptide 6 (TRAP test), adenosine-5'-diphosphate (ADP test) and arachidonic acid (ASPI test) expressed in arbitrary units area under the curve and neurological events in patients undergoing carotid thrombendarterectomy
TRAP, ADP and ASPI thresholds to predict neurological eventsimmediately before the surgeryIt will be find the best cut-off for TRAP, ADP and, ASPI in predicting neurological events

Secondary

MeasureTime frameDescription
Occurence of thromboembolic neurological eventswithin 1 month of patients' enrolled or before the hospital discharge
Occurrence of any complicationswithin 1 month of patients' enrolled or before the hospital dischargeOccurrence of surgical and medical complications
6 months and 1 year mortality6 months and 1 yearMortality at 6 months and 1 years after carotid surgery
6 months and 1 year neurological events6 months and 1 yearOccurrence of neurological events after 6 months and 1 year after the procedure

Countries

Italy

Contacts

PRINCIPAL_INVESTIGATORFabrizio Monaco, MD

San Raffaele Scientific Institute

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 1, 2026